The True Cost of a Bad Regulatory Hire (And How to Avoid It)

In life sciences, a bad hire in regulatory affairs isn't just an HR problem. It's a business risk that can delay product launches, lead to millions lost in revenue, and keep life-saving therapies from getting to the patients who need them.

Here's what a bad regulatory hire actually costs and how to avoid making an expensive mistake.

The Obvious Costs

The direct expenses add up quickly. You're paying salary and benefits during their tenure (often $150K-$250K+ annually for mid to senior regulatory roles), then recruiting costs to replace them, plus the onboarding and training time that pulls your experienced staff away from critical work. For a senior regulatory hire who doesn't work out after six months, you're easily looking at $100K-$150K in direct costs before you even factor in the real damage.

The Hidden Costs

The direct costs are painful, but the indirect costs can be devastating.

Timeline delays.

In the race to market, every month matters. A regulatory professional who misses filing deadlines, submits incomplete packages, or doesn't understand FDA expectations can add 6-12 months to your timeline. For a product with $500M in peak sales potential, every month of delay represents roughly $40M in lost revenue.

Damaged regulatory relationships.

The FDA has a long memory. A poorly prepared pre-IND meeting, a sloppy submission, or contentious interactions with reviewers can set a tone that follows your product through its entire regulatory lifecycle. We've seen companies spend years rebuilding credibility after one bad regulatory hire burned bridges.

Team morale and turnover.

Strong regulatory professionals won't stick around to watch a train wreck. When a bad hire is leading submissions or making strategic decisions, your best people start looking elsewhere. Losing your experienced regulatory specialists on top of the bad hire compounds the problem exponentially.

Investor confidence.

Missing regulatory milestones affects your valuation and your ability to raise capital. Boards and investors understand that regulatory delays often signal deeper organizational problems.

Why Smart Companies Still Make Bad Regulatory Hires

If the stakes are so high, why does this keep happening?

Hiring for credentials over capability.

A resume showing Pfizer, Merck, and Johnson & Johnson looks impressive. But did that candidate actually lead submissions, or were they a small cog in a large machine? Big pharma experience doesn't automatically translate to the scrappy, all-hands environment of a startup or mid-size biotech.

Moving too fast (or too slow).

Desperation leads to poor decisions. When you're eight weeks from a planned submission and don't have a regulatory lead, you're vulnerable to settling. Conversely, dragging out the process for months means top candidates accept other offers while you deliberate.

Ignoring cultural fit.

Regulatory affairs requires collaboration across R&D, quality, manufacturing, and clinical. A brilliant regulatory strategist who can't work cross-functionally or communicate effectively with the FDA will create more problems than they solve.

Not checking references thoroughly.

Generic references that confirm dates of employment don't tell you what you need to know. Did this person actually drive successful submissions? How did they handle setbacks? What's their reputation with the FDA?

How to Avoid the Costly Mistake

Here are a few tips to navigate smarter hiring.

Define success clearly. Before you write the job description, get specific about what this person needs to accomplish in their first year. Leading a 510(k) submission is different from developing regulatory strategy for a novel gene therapy. Clarity prevents mismatched expectations.

Assess actual experience, not just exposure. In interviews, dig into specific examples. How did they navigate a CRL? What was their role in their most recent approval? Who did they interact with at the FDA, and what was the outcome? Vague answers are red flags.

Test for problem-solving, not just knowledge. Present real scenarios your company is facing. How would they approach a particular regulatory pathway decision? Their thought process matters more than having all the right answers immediately.

Invest in thorough reference checks. Speak with people who've worked directly with the candidate. Ask specific questions about their work quality, communication style, and ability to handle pressure.

Work with specialized recruiters. Generic recruiters often don't understand the nuances between someone who can support regulatory work and someone who can lead it. Specialized life sciences recruiters have the networks and expertise to identify candidates who've actually done what you need.

Getting It Right Matters

A great regulatory hire accelerates your timeline, strengthens FDA relationships, and gives your investors confidence. A bad one can derail your entire program.

The companies that consistently make strong regulatory hires treat it as a strategic decision, not just a staffing need. They invest time upfront to get it right because they understand the true cost of getting it wrong.

At JBK Search, we've spent 26 years learning to spot the difference between regulatory professionals who look good on paper and those who actually deliver results. Because in life sciences, the right hire doesn't just fill a role—they help bring life-saving therapies to patients who can't afford to wait.